Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Alprazolam 0.25mg Tablet – PA0711/140/001
- Arava 20mg Tablet – EU/1/99/118/007
- Cozaar 50mg Film Coated Tablet – PA1286/004/002
- Letrozole Teva 2.5mg Film Coated Tablet – PA0749/085/001
- Menopur 600IU Powder and Solvent for Solution for Injection – PA1009/015/002
- Syntocinon 10IU/ml Concentrate for Solution for Infusion or Intramuscular Injection – PA2206/003/002
- Xanax 0.25mg Tablet – PA0822/141/002
- Xanax 0.5mg Tablet – PA0822/141/003
The following shortage has been resolved and supply has resumed to the Irish market:
- Bupivacaine 2.5mg/ml Solution for Injection – PA2315/058/001
- Bupivacaine 5mg/ml Solution for Injection – PA2315/058/002
- By-Mycin 100mg Capsule – PA1457/010/002
- Co-Amoxiclav 1000mg/200mg Powder for Solution for Injection and Infusion – PA0749/011/002
- Co-Amoxiclav 1000mg/200mg Powder for Solution for Injection and Infusion – PA1457/001/001
- Esomeprazole Krka 20mg Gastro-Resistant Capsule – PA1347/017/001
- Galfer 305mg Capsule – PA0126/314/001
- Innohep 14,000IU in 0.7ml Solution for Injection – PA0046/060/011
- Mercilon 150mcg/20mcg Tablet – PA1286/052/001
- Teveten 600mg Film Coated Tablet – PA2010/017/002
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.